GMP peptide Service
Peptide under GMP standard, available for both API and neoantigen peptide
Receive your quote directly from the manufacturer.
Provides reliable one-stop services from peptide drug development, IND filing to clinical trials. Our professional regulatory affairs team also provides extensive support in CMC filing documents and the development of global regulatory strategies for peptide new drugs.
Accelerate neoantigen-based immunotherapy development for cancer treatment
Overcome challenges in neoantigen-based immunotherapy development and leverage synthetic peptides for cancer treatment.
Synthetic peptides are indispensable across all phases of immunotherapy, from discovery and development to manufacturing. Identifying neoantigen peptides is essential for creating personalized cancer vaccines and T cell therapies, driving the advancement of highly targeted and effective treatments.
This eBook aims to address the significant challenges faced by scientists and laboratory professionals in the timely generation of reagents essential for accelerating patient therapies.
Download to learn more about:
- The applications of synthetic peptides
- Advancing shared neoantigen-based immunotherapies
- Validating neoantigen-reactive T-cell receptors
- Bioinformatics tools for peptide synthesis
- Rapid cGMP peptide manufacturing
- Neoantigen peptide synthesis for precision therapeutics
- Developing personalized neoantigen vaccines
Gene and cell therapy: Research and development support
In this infographic, GenScript presents its solutions to support gene and cell therapy research and development. GenScript presents solutions for target selection and validation, CRISPR editing and payload optimization, and transgene delivery optimization. Plus, GenScript explores solutions for extensive testing in animal models for feasibility, efficacy and safety, and cGMP manufacturing, documentation, and support to accelerate IND filing.
